Search hospitals > Michigan > Novi

Henry Ford Medical Center-Columbus

Claim this profile
Novi, Michigan 48377
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
139 reported clinical trials
5 medical researchers
Photo of Henry Ford Medical Center-Columbus in NoviPhoto of Henry Ford Medical Center-Columbus in NoviPhoto of Henry Ford Medical Center-Columbus in Novi

Summary

Henry Ford Medical Center-Columbus is a medical facility located in Novi, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Henry Ford Medical Center-Columbus is involved with conducting 139 clinical trials across 321 conditions. There are 5 research doctors associated with this hospital, such as Ding Wang, Haythem Y. Ali, Eleanor M. Walker, and Stuart Gordon.

Area of expertise

1Cancer
Global Leader
Henry Ford Medical Center-Columbus has run 41 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Henry Ford Medical Center-Columbus has run 16 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
Stage IV
PR positive

Top PIs

Clinical Trials running at Henry Ford Medical Center-Columbus

Non-Small Cell Lung Cancer
Bladder Carcinoma
Lung Cancer
Squamous Cell Carcinoma
Renal Cell Carcinoma
Cancer
Bladder Cancer
Breast Cancer
Prostate Cancer
Follicular Lymphoma
Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This study is evaluating whether the addition of a drug to chemotherapy may help treat non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This study is evaluating whether a drug called crizotinib may help treat patients with non-small cell lung cancer.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

PF-07799933

for Advanced Cancers

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07799933) administered as a single agent and in combination with other study medicines (called binimetinib) in people with solid tumors. This study is seeking participants who have an advanced solid tumor with a certain type of abnormal gene called "BRAF" and available treatments are no longer effective in controlling their cancer. All participants in this study will receive PF-07799933. PF-07799933 comes as a tablet to take by mouth, 2 times a day. Depending on the part of the study, participants may also receive another study medicine: People with melanoma or other solid tumors may also receive binimetinib. Binimetinib comes as a tablet to take by mouth, 2 times a day. People with colorectal cancer may also receive cetuximab. Cetuximab will be given weekly (or every two weeks) in the clinic as a shot given in the vein or port (intravenous, IV). Participants may receive the study medicines for about 2 years. The study team will monitor how each participant is doing with the study treatment during regular visits at the study clinic.
Recruiting1 award Phase 14 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Henry Ford Medical Center-Columbus?
Henry Ford Medical Center-Columbus is a medical facility located in Novi, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Henry Ford Medical Center-Columbus is involved with conducting 139 clinical trials across 321 conditions. There are 5 research doctors associated with this hospital, such as Ding Wang, Haythem Y. Ali, Eleanor M. Walker, and Stuart Gordon.